Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15101 - 15125 of 15341 in total

PAS219

Experimental

(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester

Experimental

FR239087

Experimental

4-Fluorophenethyl Alcohol

Experimental

Phenacetin

Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn

1,3,5-trichlorobenzene

Experimental

4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid

Experimental

1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea

Experimental

N-(Chlorophenyl)-N'-hydroxyguanidine

Experimental

(R)-4-Nitrostyrene oxide

Experimental

Cannabinor

Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational

Indisulam

Investigational

1-[4-(hydroxymethyl)phenyl]guanidine

Experimental

N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE

Experimental

4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide

Experimental

1-(4-thiophen-2-ylphenyl)methanamine

Experimental

2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE

Experimental

5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide

Experimental

4-(2-aminoethyl)-2-ethylphenol

Experimental

(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid

Experimental

(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE

Experimental

Bromamphenicol

Experimental

4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE

Experimental

4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid

Experimental

Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium

Experimental
Displaying drugs 15101 - 15125 of 15341 in total